ASTRAZENECA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,878 GBX | -1.32% |
|
+1.59% | +2.62% |
| 03:14pm | Market sentiment sours |  |
| 03:03pm | ASTRAZENECA : Deutsche Bank returns to 'Hold | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
137.3
USD
Average target price
162.5
USD
Spread / Average Target
+18.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.62% | 213B | |
| +28.33% | 676B | |
| +24.27% | 559B | |
| -7.51% | 356B | |
| +15.08% | 320B | |
| +5.31% | 286B | |
| +0.15% | 207B | |
| -9.41% | 199B | |
| -7.92% | 142B | |
| -3.31% | 116B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Gives Switzerland 10,000 Doses of Flu Spray for Free After Pricing Disagreement with Regulators
